Literature DB >> 16625671

Comparison of EQ-5D and SF-6D utilities in mental health patients.

L M Lamers1, C A M Bouwmans, A van Straten, M C H Donker, L Hakkaart.   

Abstract

Various preference-based measures of health are available for use as an outcome measure in cost-utility analysis. The aim of this study is to compare two such measures EQ-5D and SF-6D in mental health patients. Baseline data from a Dutch multi-centre randomised trial of 616 patients with mood and/or anxiety disorders were used. Mean and median EQ-5D and SF-6D utilities were compared, both in the total sample and between severity subgroups based on quartiles of SCL-90 scores. Utilities were expected to decline with increased severity. Both EQ-5D and SF-6D utilities differed significantly between patients of adjacent severity groups. Mean utilities increased from 0.51 at baseline to 0.68 at 1.5 years follow-up for EQ-5D and from 0.58 to 0.70 for SF-6D. For all severity subgroups, the mean change in EQ-5D utilities as well as in SF-6D utilities was statistically significant. Standardised response means were higher for SF-6D utilities. We concluded that both EQ-5D and SF-6D discriminated between severity subgroups and captured improvements in health over time. However, the use of EQ-5D resulted in larger health gains and consequent lower cost-utility ratios, especially for the subgroup with the highest severity of mental health problems. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16625671     DOI: 10.1002/hec.1125

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  59 in total

1.  Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients.

Authors:  Lene Lunde
Journal:  Eur J Health Econ       Date:  2012-06-08

2.  Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Authors:  Oriol Cunillera; Ricard Tresserras; Luis Rajmil; Gemma Vilagut; Pilar Brugulat; Mike Herdman; Anna Mompart; Antonia Medina; Yolanda Pardo; Jordi Alonso; John Brazier; Montse Ferrer
Journal:  Qual Life Res       Date:  2010-03-31       Impact factor: 4.147

3.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Comparing SF-6D and EQ-5D utilities across groups differing in health status.

Authors:  Nick Kontodimopoulos; Evelina Pappa; Angelos A Papadopoulos; Yannis Tountas; Dimitris Niakas
Journal:  Qual Life Res       Date:  2008-11-29       Impact factor: 4.147

5.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

6.  The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.

Authors:  Nick Kontodimopoulos; Michalis Argiriou; Nikolaos Theakos; Dimitris Niakas
Journal:  Eur J Health Econ       Date:  2010-05-15

7.  Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.

Authors:  Maria Bjerk; Therese Brovold; Jennifer C Davis; Astrid Bergland
Journal:  Qual Life Res       Date:  2019-07-30       Impact factor: 4.147

8.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

9.  Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Authors:  Carmen Selva-Sevilla; Paula Ferrara; Manuel Gerónimo-Pardo
Journal:  Eur J Health Econ       Date:  2020-02-17

10.  Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).

Authors:  Sowmyanarayanan Thuppal; Stephen Markwell; Traves Crabtree; Stephen Hazelrigg
Journal:  Qual Life Res       Date:  2019-02-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.